AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 17205281
Drug: Ondansetron 24
RxNorm normalized name: ondansetron 24 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 24 or 32 mg
Trial: 17205281
Drug: Ondansetron higher
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron higher doses (24 or 32 mg)
Trial: 16041629
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (200 microg every 12 hours) + Isosorbide dinitrate (5 mg single dose)
Trial: 7579103
Drug: Alfentanil 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 50 micrograms/kg, propofol at 10 mg/kg/h, reduced to 1 microgram/kg/min after 4 min.
Trial: 7579103
Drug: Alfentanil 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil 75 micrograms/kg, propofol at 10 mg/kg/h, reduced to 2 micrograms/kg/min after 4 min.
Trial: 2135712
Drug: Biperiden 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biperiden 2.5 mg
Trial: 2135712
Drug: Atropine 1.5
RxNorm normalized name: homatropine 1.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine 1.5 mg
Trial: 7001207
Drug: Guanfacine (3.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanfacine (3.3 mg daily)
Trial: 7001207
Drug: Clonidine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (0.5 mg daily)
Trial: 26275705
Drug: Pharmacotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy plus cognitive‐coping therapy (pCCT)
Trial: 26275705
Drug: Pharmacotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacotherapy plus psychological support (PPS)
Trial: 21303262
Drug: LGNC-07 (1,680
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LGNC-07 (1,680 mg for 16 weeks)
Trial: 21303262
Drug: LGNC-07 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LGNC-07 (single dose)
Trial: 19843667
Drug: p16(INK4a) ELISA
RxNorm normalized name: PSEUDOPTEROGORGIA ELISABETHAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p16(INK4a) ELISA (enhanced version, >or=6 pg/mL cut-point)
Trial: 19843667
Drug: p16(INK4a) ELISA
RxNorm normalized name: PSEUDOPTEROGORGIA ELISABETHAE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: p16(INK4a) ELISA (original version, >or=8 pg/mL cut-point)
Trial: 14962398
Drug: Verbal prompts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verbal prompts during task preparation
Trial: 11343529
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 to 200 mg daily for 12 weeks)
Trial: 9392394
Drug: Lispro insulin
RxNorm normalized name: Lispro insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lispro insulin injected immediately before breakfast
Trial: 9392394
Drug: Regular insulin
RxNorm normalized name: Regular insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular insulin injected 20 min preprandially
Trial: 7516978
Drug: Leuprolide 3.75
RxNorm normalized name: leuprolide 3.75 mg intramuscular powder for injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide 3.75 mg depot injection every 28 days for 24 weeks
Trial: 30859848
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of vitamin C-enriched gelatin
Trial: 30859848
Drug: 15 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 g of hydrolyzed collagen (HC)
Trial: 26028449
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of interactive seminar and training of practice nurses
Trial: 23550861
Drug: Omega-3 (1,500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 (1,500 mg daily for 6 months)
Trial: 19253801
Drug: Sodium phosphate
RxNorm normalized name: Sodium Phosphate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium phosphate preparation
Trial: 21225849
Drug: Intravenous injection
RxNorm normalized name: Meta Trace FDG, intravenous injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous injection of 0.46 mg/kg dose of cocaine
Trial: 7667717
Drug: 5-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-day regimen (300 mg initial dose followed by 100 mg for another 4 days)
Trial: 7667717
Drug: 7-day regimen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 7-day regimen (160 mg initial dose followed by 80 mg daily for another 6 days)
Trial: 29745804
Drug: 1,000 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,000 µg salbutamol (SAL)
Trial: 25564322
Drug: Daikenchuto (DKT)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daikenchuto (DKT) 7.5 g/day, t.i.d. for 3 months
Trial: 16429299
Drug: Isotretinoin 0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotretinoin 0.8 mg/kg for 4 weeks
Trial: 15143418
Drug: Salbutamol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salbutamol (200 micro g)
Trial: 15143418
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (36 micro g)
Trial: 1615182
Drug: Amoxy 500
RxNorm normalized name: Amoxi Drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxy 500 mg plus bromhexeine 8 mg
Trial: 1615182
Drug: Plain amoxy
RxNorm normalized name: Amoxi Drop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain amoxy 500 mg
Trial: 6389377
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg) after fasting
Trial: 6389377
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg) with antacid
Trial: 6389377
Drug: Captopril (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (50 mg) after a meal
Trial: 28952218
Drug: Javanica oil
RxNorm normalized name: javanicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Javanica oil emulsion injection (JOEI) combined with radiotherapy (RT)
Trial: 25127208
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ponesimod
Trial: 25127208
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg ponesimod
Trial: 25127208
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ponesimod (maintenance)
Trial: 25127208
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg ponesimod (maintenance)
Trial: 25127208
Drug: Placebo (swapped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (swapped from 20 mg)
Trial: 25127208
Drug: Placebo (swapped
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (swapped from 40 mg)
Trial: 17290061
Drug: Ifosfamide 1.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ifosfamide 1.6 g/m2 IV daily for 3 days plus paclitaxel 135 mg/m2 by 3‐hour infusion on day 1 (arm 2)
Trial: 17290061
Drug: Ifosfamide 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ifosfamide 2.0 g/m2 IV daily for 3 days (arm 1)
Trial: 15458510
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (chemo and radiotherapy)
Trial: 7519979
Drug: Clonidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (150 micrograms in 10 mL of saline)
Trial: 7519979
Drug: Synthetic porcine
RxNorm normalized name: Secretin synthetic porcine
DrugBank: Secretin porcine (DB09527)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synthetic porcine galanin (500 micrograms in 100 mL of saline)
Trial: 3287815
Drug: 3 g
RxNorm normalized name: Molds 3 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g metronidazole
Trial: 3287815
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g metronidazole + 3 g nalidixic acid
Trial: 3287815
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g metronidazole (3-4 hours preoperatively)
Trial: 28549439
Drug: Abdominal aortic
RxNorm normalized name: chloroxylenol / hydrocortisone / pramoxine hydrochloride Otic Solution [Cortic]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abdominal aortic balloon occlusion (AABO) in combination with cesarean section
Trial: 23620949
Drug: 2 Hz/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 Hz/100 Hz EA treatment group (group B)
Trial: 23620949
Drug: 2 Hz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 Hz EA treatment group (group A)
Trial: 23620949
Drug: 100 Hz
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 Hz EA treatment group (group C)
Trial: 16939905
Drug: Tazarotene treatment
RxNorm normalized name: Tazarotene
DrugBank: Tazarotene (DB00799)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tazarotene treatment
Trial: 12671829
Drug: Oral calcitriol
RxNorm normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral calcitriol pulse therapy (twice weekly for 3 months)
Trial: 12671829
Drug: Placebo (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (twice weekly for 3 months)
Trial: 10630940
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide in an oral base 0.1%
Trial: 10630940
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide gel no. 1
Trial: 10630940
Drug: Fluocinolone acetonide
RxNorm normalized name: Fluocinolone Acetonide
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinolone acetonide gel no. 2
Trial: 9175396
Drug: Dexamethasone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (0.5 mg/kg/dose daily for 3 days)
Trial: 31935026
Drug: Counseling behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Counseling behavioral intervention promoting consumption of 7 or more daily vegetable servings (MEAL intervention; n=237)
Trial: 25175875
Drug: Mass drug
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass drug administration with praziquantel
Trial: 22246963
Drug: Commercial drug
RxNorm normalized name: iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Commercial drug alerts
Trial: 19246726
Drug: PM101 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PM101 (150 mg)
Trial: 21257800
Drug: Intravenous amiodarone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous amiodarone (150 mg)
Trial: 14747042
Drug: Estramustine (280
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estramustine (280 mg tid, days 1 to 5) and docetaxel (70 mg/m2 on day 2) before radical prostatectomy (RP)
Trial: 10718464
Drug: Antireflux therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antireflux therapy (nizatidine)
Trial: 9177894
Drug: Trypsin: chymotrypsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trypsin: chymotrypsin (Chymoral forte DS) preparation
Trial: 8263885
Drug: Hydroflumethiazide 50
RxNorm normalized name: hydroflumethiazide 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroflumethiazide 50 mg and Reserpine 0.125 mg (H-R)
Trial: 8263885
Drug: Chlortalidone 12.5
RxNorm normalized name: Atenolol 50 mg and chlortalidone 12.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlortalidone 12.5 mg and Atenolol 50 mg (C-A)
Trial: 2939815
Drug: Subcutaneous catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous catheter irrigated with antibiotic
Trial: 2939815
Drug: Subcutaneous catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous catheter irrigated with saline
Trial: 2939815
Drug: Subcutaneous catheter
RxNorm normalized name: CATHETER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous catheter alone
Trial: 31780023
Drug: Oil pulling
RxNorm normalized name: JASMINUM SAMBAC WHOLE 0.119 g in 119 g / ORIGANUM VULGARE LEAF OIL 0.119 g in 119 g / FOENICULUM VULGARE (FENNEL) SEED EXTRACT 0.119 g in 119 g / MENTHA VIRIDIS (SPEARMINT) LEAF OIL 0.119 g in 119 g / ALPINIA KATSUMADAI SEED EXTRACT 0.119 g in 119 g ORAL PASTE [YOUBUY post oil pulling tooth-paste]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oil pulling therapy with coconut oil
Trial: 29920852
Drug: Morphine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 1.5 mg
Trial: 29920852
Drug: Morphine in
RxNorm normalized name: morphine Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine in trapezius muscle
Trial: 25166443
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel (Aqua Touch™) applied immediately before cystoscopy (Group 2)
Trial: 25166443
Drug: Lidocaine gel
RxNorm normalized name: LIDOCAINE 4 g in 100 g EXTRACORPOREAL PATCH [Arthcal 4% Lidocaine Gel Patches]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine gel (Aqua Touch™) applied with a 10-minute clamping before cystoscopy (Group 3)
Trial: 19666195
Drug: Mindfulness-Based Cognitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Cognitive Therapy + Treatment As Usual (MBCT+TAU)
Trial: 16202291
Drug: 3 day
RxNorm normalized name: Kathro 3 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 day miconazole (400 mg/d)
Trial: 16202291
Drug: 6 day
RxNorm normalized name: Kathro 6 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 day miconazole (400 mg/d)
Trial: 16202291
Drug: 7 day
RxNorm normalized name: ZonaCort 7 Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 day miconazole (200 mg/d)
Trial: 12891550
Drug: Regular milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular milk products (calcium supply, 1100 mg/day)
Trial: 12891550
Drug: Placebo milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo milk products (calcium supply, 60 mg/day)
Trial: 1831628
Drug: Ondansetron plus
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron plus dexamethasone (ondansetron 0.15 mg/kg IV every 2 hours + dexamethasone 20 mg IV single dose)
Trial: 1831628
Drug: Ondansetron alone
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ondansetron alone (ondansetron 0.15 mg/kg IV every 2 hours)
Trial: 25649640
Drug: Avizor Alvera®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avizor Alvera® (study solution)
Trial: 25649640
Drug: All Clean
RxNorm normalized name: Water, Sea Otic Solution [ALL CLEAN EAR CLEANSING SYSTEM]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All Clean Soft® (control solution)
Trial: 24819510
Drug: Low-molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular weight heparin (LMWH) along with physical measures (compression stockings)
Trial: 21849647
Drug: Interferon β‐1b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon β‐1b (250 μg, subcutaneously every other day for 2 years)
Trial: 22227558
Drug: risperidone 6
RxNorm normalized name: risperidone 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risperidone 6 mg/day
Trial: 22227558
Drug: haloperidol 20
RxNorm normalized name: haloperidol 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: haloperidol 20 mg/day
Trial: 19139851
Drug: Medication-free SCH
RxNorm normalized name: SCH-58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication-free SCH patients
Trial: 17456248
Drug: Multivitamin tablets
DrugBank: Nicotinamide (DB02701)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multivitamin tablets (n 28)
Trial: 17456248
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil capsules (n 27)
Trial: 12841346
Drug: Coenzyme Q10
RxNorm normalized name: Coenzyme Q10
DrugBank: Ubidecarenone (DB09270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Coenzyme Q10 (120 mg/day)
Trial: 10543679
Drug: Sequential transdermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential transdermal progesterone with continuous transdermal oestrogen
Trial: 31027120
Drug: Submucosal bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submucosal bupivacaine injection
Trial: 22440906
Drug: Conventional solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional solution
Trial: 27779568
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated estrogens (o‐CEE) 0.45 mg (n=230)
Trial: 27779568
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol (t‐E2) 50 μg (n=225)
Trial: 19195512
Drug: Probucol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probucol (500 mg orally twice daily)
Trial: 10353511
Drug: Ceftriaxone, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone, 50 mg/kg (single intramuscular dose)
Trial: 10353511
Drug: Amoxicillin/clavulanate, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin/clavulanate, 80 mg/kg/day of amoxicillin: 10 mg/kg/day of clavulanate for 10 days
Trial: 1770473
Drug: Combined lipid-lowering
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined lipid-lowering and antihypertensive treatment
Trial: 29222893
Drug: Krill oil
RxNorm normalized name: Krill oil
DrugBank: Krill oil (DB16615)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill oil (KO) - 5 capsules (907 mg LC n-3 PUFA)
Trial: 29222893
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil (FO) - 5 capsules (1441 mg LC n-3 PUFA)
Trial: 22444237
Drug: Preoperative carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative carbohydrate treatment (PCT) - 600 ml of a carbohydrate-based drink (ONS, Fresenuis Kabi, 50 g carbohydrate, 15 g glutamine and antioxidants/300 ml)
Trial: 22444237
Drug: Placebo -
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo - 600 ml of a carbohydrate-free drink (0 g carbohydrate)
Trial: 27152748
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg IV-ibuprofen every 6 hours
Trial: 17907107
Drug: Tesaglitazar 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tesaglitazar 0.25 mg
Trial: 17907109
Drug: Tesaglitazar 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tesaglitazar 0.5 mg
Trial: 17907108
Drug: Tesaglitazar 1
RxNorm normalized name: Tesaglitazar
DrugBank: Tesaglitazar (DB06536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tesaglitazar 1 mg
Trial: 17907107
Drug: Tesaglitazar (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tesaglitazar (all doses)
Trial: 10570375
Drug: Tazarotene 0.1%
RxNorm normalized name: TAZAROTENE 0.1% GEL,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tazarotene 0.1% gel pretreatment 3 times per week for 2 weeks
Trial: 10570375
Drug: Thin application
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thin application of tazarotene gel immediately before phototherapy
Trial: 10570375
Drug: Thick application
RxNorm normalized name: tick-borne encephalitis purified antigen Prefilled Syringe [Ticovac]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thick application of tazarotene gel immediately before phototherapy
Trial: 23427393
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (Group A)
Trial: 8635058
Drug: Intensive therapy
RxNorm normalized name: Cortaid Intensive Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive therapy (Group B)
Trial: 2127226
Drug: N-acetylcysteine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (400 mg)
Trial: 23530969
Drug: HQK-1001 (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HQK-1001 (20 mg/kg per day)
Trial: 16729930
Drug: Atorvastatin, 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin, 80 mg daily
Trial: 22085316
Drug: Rosuvastatin, 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosuvastatin, 40 mg daily
Trial: 19088267
Drug: AMG 487
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 487 at 25 mg
Trial: 19088267
Drug: AMG 487
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 487 at higher doses (not specified)
Trial: 18193495
Drug: Carraguard gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carraguard gel applied vaginally once per day for 14 days (women)
Trial: 18193495
Drug: Carraguard gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carraguard gel applied directly to the penis once per day for 7 days (men)
Trial: 11528360
Drug: Red clover
RxNorm normalized name: Red clover
DrugBank: Trifolium pratense pollen (DB15530)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red clover isoflavones (approximately 50 mg)
Trial: 2901993
Drug: Acrivastine (BW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acrivastine (BW 825C; 8 mg 3 times daily)
Trial: 2901993
Drug: Cyproheptadine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproheptadine (4 mg 3 times daily)